December 12, 2024 – Call for entrepreneurs and scientists to pitch your Ontario-made cancer innovation for a chance to win the $100,000 award. Falcons’ Fortunes is FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research community. Apply by January 10, 2025.
Read More from Pitch Your Cancer Innovation at Falcons’ Fortunes 2025
March 12, 2024 – You are invited to attend Falcons’ Fortunes, FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research and innovation communities. Now in its 11th year, the Falcons’ Fortunes event features six Ontario rising stars pitching their breakthrough cancer innovation as they compete for the $100,000 Ernsting Entrepreneurship Award.
Read More from Registration is now open for the 2024 Falcons’ Fortunes Pitch Finals – LIVE!
January 31, 2024 – Apply Now! FACIT invites entrepreneurs and scientists to pitch their Ontario-made cancer innovation to a panel of judges and in front of a live audience for a chance to win the $100,000 award. Falcons’ Fortunes is FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research community to drive a culture of commercialization where Ontario-based cancer research discoveries becomes Ontario-made solutions to benefit patients worldwide.
Read More from Falcons’ Fortunes 2024 – Pitch Your Cancer Innovation
August 2, 2023 – FACIT and T-CAIREM announce partnership to commercialize medical artificial intelligence (AI) innovations. The partners intend to harness both T-CAIREM’s innovative translational research in AI and FACIT’s unique commercialization-venture model to build the next generation of Ontario biotechnology companies. The joint mission will accelerate the benefits of AI research to support patients battling cancer.
Read More from FACIT and T-CAIREM at the University of Toronto partner to commercialize medical AI
March 29, 2023 – FACIT announced $1.5 billion in follow-on investment attracted to its portfolio of cancer biotechnology start-ups in Ontario, a significant milestone for life science commercialization in Canada.
Read More from FACIT generates $1.5 billion in follow-on investment
March 23, 2023 – CTRL Therapeutics (“CTRL”) closed a seed financing round to develop a tumor-infiltrating lymphocyte (TIL) therapy for solid tumours. CTRL is advancing novel, non-invasive and less costly therapies for patients living with cancer.
February 21, 2023 – This year marks the 10th anniversary of the FACIT Falcons’ Fortunes pitch competition! Be part of the audience and watch the six finalists pitch their Ontario oncology innovations.
Read More from Registration is now open for FACIT Falcons’ Fortunes pitch competition and reception
May 18, 2021 – May 18, 2021 – FACIT deploys Ontario First capital, enables rising local start-up to reach critical value inflection point. FACIT has previously supported Nanology, spun out of the University of Toronto, through both its early-stage Prospects Oncology Fund and seed-stage Compass Rose Oncology Fund.
January 26, 2021 – January 26, 2021 – Mr. Newport is a passionate executive and advocate of Ontario’s life science sector, having decades of leadership experience in both public and private ventures.
December 10, 2020 – December 10, 2020 – The newest recipients of Ontario First seed capital include Dr. Rebecca Laposa of the University of Toronto, as well as London-based start-up Multi-Magnetics Inc.